March 14, 2025 | Myeloma patients face several issues, one being compromised immune systems that make them more prone to infection. The UAMS Division of Infectious Diseases plays an important role in ensuring patients are in the best position to continue their cancer treatment. Under the direction of Michael Saccente, M.D., the Division of Infectious Diseases is part of...
March 14, 2025 | By Frits van Rhee, M.D., Ph.D. Castleman disease was first described in 1954 by Benjamin Castleman, M.D., longtime chief of the Division of Anatomic Pathology at Massachusetts General Hospital in Boston. Patients with Castleman disease have enlargement of one or more lymph node areas. Patients who have the disease in one area, unicentric Castleman disease,...
March 14, 2025 | At the UAMS Myeloma Center, Fenghuang (Frank) Zhan, M.D., Ph.D., knows that research plays an immensely important role in the fight against multiple myeloma. Numerous federal grants allow the center’s director of research and his team to continue to advance and improve treatments, benefitting myeloma patients around the world. The latest is a $1.1 million...
March 14, 2025 | Multiple myeloma treatment is advancing with the advent of bispecific antibody drugs, which use the patient’s T cells to fight the disease. Myeloma Center physicians and researchers Carolina Schinke, M.D., and Samer Al Hadidi, M.D., M.S., are leading clinical trials exploring combinations of these novel therapies. Schinke’s trial is studying the effects of using teclistamab...
March 14, 2025 | Rob Guba, Burke Moran and Chris Seab grew up together in Baton Rouge, Louisiana. When Seab was diagnosed with multiple myeloma in May 2024, Guba and Moran decided to do something. That something is a project called Wheeling for Healing, a cross-country e-bike ride to raise money not only in support of their friend but...
March 13, 2025 | LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has joined a network of institutions funded by the National Institutes of Health (NIH) to expand research in rural primary care clinics. Through the NIH CARE for Health™ initiative, UAMS will help lead innovative research to address health disparities in Arkansas’ rural areas. UAMS,...
March 12, 2025 | UAMS’ Spyridoula Maraka, M.D., has been awarded a Veterans Affairs (VA) Merit Award of $830,000 over four years to address the widespread overprescribing of levothyroxine (LT4), one of the most prescribed drugs in the United States. LT4 is used to treat hypothyroidism, a condition where the thyroid produces too few hormones. However, many patients are...
March 12, 2025 | Justin M. McLawhorn, M.D., a Vanderbilt-trained dermatologic oncologist and skin cancer surgeon, has joined the University of Medical Sciences (UAMS) as director of dermatologic oncology. McLawhorn specializes in the treatment of skin cancers, including melanoma, basal cell carcinoma and squamous cell carcinoma. Board certified in dermatology and fellowship trained and board certified in micrographic surgery,...
March 11, 2025 | LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) is taking action against one of the state's most urgent public health challenges by hosting a forum dedicated to suicide prevention and awareness. The initiative aims to equip attendees with potentially life-saving knowledge and strategies.
March 10, 2025 | LITTLE ROCK — Researchers at the University of Arkansas for Medical Sciences (UAMS) Institute for Community Health Innovation found that excessive gestational weight gain is linked to an increase in cesarean sections, according to a study published recently in the American Journal of Obstetrics and Gynecology. The percentage of women in the United States who...